Denali Therapeutics (DNLI) Earnings Date, Estimates & Call Transcripts $14.52 -0.83 (-5.41%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$14.52 0.00 (-0.03%) As of 07/11/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Denali Therapeutics Earnings Summary Denali Therapeutics announced Q1 2025 earnings on May 6, 2025, reporting an EPS of -$0.78, which missed the consensus estimate of -$0.71 by $0.07. With a trailing EPS of -$2.67, Denali Therapeutics' earnings are expected to decrease next year, from ($2.71) to ($3.03) per share. Upcoming Q2 Earnings DateJul. 30Before Market OpensEstimatedConsensus EPS (May. 6) -$0.71 Actual EPS (May. 6) -$0.78 Missed By -$0.07 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)DNLI Upcoming EarningsDenali Therapeutics' Q2 2025 earnings is scheduled for Wednesday, July 30, 2025, with a conference call scheduled on Friday, August 1, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Denali Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Denali Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataDNLI Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.DNLI Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Denali Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20254-$0.83-$0.69-$0.78Q2 20255-$0.86-$0.68-$0.77Q3 20256-$0.86-$0.68-$0.79Q4 20256-$0.89-$0.71-$0.82 FY 2025 21 -$3.44 -$2.76 -$3.16 Q1 20262-$0.85-$0.79-$0.82Q2 20262-$0.79-$0.78-$0.79Q3 20262-$0.79-$0.78-$0.79Q4 20262-$0.78-$0.77-$0.78 FY 2026 8 -$3.21 -$3.12 -$3.17 Q1 20271-$0.74-$0.74-$0.74 Denali Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 7/30/2025(Estimated)--------5/6/2025Q1 2025-$0.71-$0.78 -$0.07-$0.78$3.24M-2/27/2025Q4 2024-$0.75-$0.67+$0.08-$0.67$12.75M-11/6/2024Q3 2024-$0.60-$0.63 -$0.03-$0.63$6.30M-8/1/2024Q2 2024-$0.68-$0.59+$0.09-$0.59$10.00M$1.00M5/7/2024Q1 2024-$0.69-$0.68+$0.01-$0.68$14.02M-2/27/2024Q4 2023-$0.81-$0.86 -$0.05-$0.86$3.38M-11/7/2023Q3 2023-$0.81-$0.72+$0.09-$0.72$11.16M$1.30M8/8/2023Q2 2023-$0.69$1.30+$1.99$1.30$39.51M$294.10M Denali Therapeutics Earnings - Frequently Asked Questions When is Denali Therapeutics' earnings date? Denali Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 30th, 2025 based off last year's report dates. Learn more on DNLI's earnings history. Did Denali Therapeutics beat their earnings estimates last quarter? In the previous quarter, Denali Therapeutics (NASDAQ:DNLI) missed the analysts' consensus estimate of ($0.71) by $0.07 with a reported earnings per share (EPS) of ($0.78). Learn more on analysts' earnings estimate vs. DNLI's actual earnings. How much revenue does Denali Therapeutics generate each year? Denali Therapeutics (NASDAQ:DNLI) has a recorded annual revenue of $330.53 million. How much profit does Denali Therapeutics generate each year? Denali Therapeutics (NASDAQ:DNLI) has a recorded net income of -$422.77 million. DNLI has generated -$2.67 earnings per share over the last four quarters. What is Denali Therapeutics' EPS forecast for next year? Denali Therapeutics' earnings are expected to decrease from ($2.71) per share to ($3.03) per share in the next year. More Earnings Resources from MarketBeat Related Companies Beam Therapeutics Earnings Results BridgeBio Pharma Earnings Results Verona Pharma PLC American Depositary Share Earnings Results Roivant Sciences Earnings Results Elanco Animal Health Earnings Results Revolution Medicines Earnings Results Legend Biotech Earnings Results Grifols Earnings Results TG Therapeutics Earnings Results Nuvalent Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles 3 Catalysts Converge on Intel Ahead of a Critical Earnings ReportSmith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s Next This page (NASDAQ:DNLI) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Denali Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Denali Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DNLI Stock Alerts